Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1999 1
2000 2
2001 1
2002 2
2003 1
2005 1
2006 1
2011 2
2012 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Results by year
Filters applied: . Clear all
Page 1
Fractionated stereotactic radiotherapy for uveal melanoma, late clinical results.
Muller K, Naus N, Nowak PJ, Schmitz PI, de Pan C, van Santen CA, Marijnissen JP, Paridaens DA, Levendag PC, Luyten GP. Muller K, et al. Among authors: paridaens da. Radiother Oncol. 2012 Feb;102(2):219-24. doi: 10.1016/j.radonc.2011.06.038. Epub 2011 Aug 22. Radiother Oncol. 2012. PMID: 21864922
Effectiveness of fractionated stereotactic radiotherapy for uveal melanoma.
Muller K, Nowak PJ, de Pan C, Marijnissen JP, Paridaens DA, Levendag P, Luyten GP. Muller K, et al. Among authors: paridaens da. Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):116-22. doi: 10.1016/j.ijrobp.2005.01.058. Int J Radiat Oncol Biol Phys. 2005. PMID: 16111579 Clinical Trial.
In vivo and in vitro detection of dopamine d2 receptors in uveal melanomas.
Bodei L, Hofland LJ, Ferone D, Mooy CM, Kros JM, Paridaens DA, Baarsma SG, Ferdeghini M, Van Hagen MP, Krenning EP, Kwekkeboom DJ. Bodei L, et al. Among authors: paridaens da. Cancer Biother Radiopharm. 2003 Dec;18(6):895-902. doi: 10.1089/108497803322702860. Cancer Biother Radiopharm. 2003. PMID: 14969602
12 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page